# China Neurorehabilitation Devices Market > China Neurorehabilitation Devices Market Research Report By Type (Neuro-Robotic Devices, Wearable Devices, Non-Invasive Stimulators, Brain-Computer Interfaces), By Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Cerebral Palsy, Schizophrenia) and By End User (Rehabilitation Centers, Hospitals & Clinics, Home Care) -Forecast to 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 9.04% - **2024:** $ 65.49 Million - **2025:** $ 71.41 Million - **2035:** $ 169.71 Million - **Key Players:** ReWalk Robotics (IL), Ekso Bionics (US), Medtronic (US), Bionik Laboratories (CA), AlterG (US), NeuroPace (US), Hocoma (CH), Tyromotion (AT), Kessler Foundation (US) **Report ID:** MRFR/MED/54291-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/china-neurorehabilitation-devices-market-56057 --- ## Market Summary ## **China Neurorehabilitation Devices Market Overview** As per MRFR analysis, the China Neurorehabilitation Devices Market Size was estimated at 60.69 (USD Million) in 2023. The China Neurorehabilitation Devices Market Industry is expected to grow from 64.74(USD Million) in 2024 to 124.45 (USD Million) by 2035. The China Neurorehabilitation Devices Market CAGR (growth rate) is expected to be around 6.121% during the forecast period (2025 - 2035)**.** **Key China Neurorehabilitation Devices Market Trends Highlighted** The China Neurorehabilitation Devices Market is currently experiencing significant growth due to several market drivers. One of the key factors fueling this expansion is the increasing prevalence of neurological disorders, such as stroke and multiple sclerosis, which has led to a higher demand for effective rehabilitation solutions. The Chinese government is also investing heavily in healthcare infrastructure and technology, enhancing access to innovative neurorehabilitation devices. This governmental support underscores the importance placed on improving patient outcomes and enhancing the quality of care for neurological conditions. There are numerous opportunities to be explored within the Chinese market, especially as advancements in technology pave the way for innovative solutions.As an illustration, incorporating AI and VR technologies into neurorehabilitation devices enables custom-tailored therapy and enhances user interaction. Furthermore, the growing concern towards mental health is directly linked with the rising need for devices designed for cognitive rehabilitation. Partnerships between local and global firms can also offer good prospects for expansion and development in the industry. There is a noticeable recent trend towards client-centric solutions focused on user convenience and the effectiveness of therapy results. A growing interest in at-home rehabilitation devices reflects changing attitudes toward patient autonomy and convenience. Furthermore, the increasing involvement of tech companies in healthcare is facilitating the development of more sophisticated neurorehabilitation tools tailored to meet the unique needs of the Chinese population. The emphasis on preventive healthcare, driven by the Chinese government’s policies, aligns well with the growth trajectory of neurorehabilitation devices, resulting in a favorable environment for innovations that can significantly enhance rehabilitation processes for patients across the nation. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **China Neurorehabilitation Devices Market Drivers** **Increase in Neurological Disorders** The prevalence of neurological disorders in China is increasing, significantly driving the demand for neurorehabilitation devices. According to the Chinese Ministry of Health, approximately 20 million individuals are currently living with stroke-related disabilities, and this figure is projected to rise due to the aging population and lifestyle changes. With stroke being a leading cause of long-term disability in the country, the push for innovative rehabilitation solutions is becoming critical.Major players such as China National Pharmaceutical Group and Mindray Medical International Limited are capitalizing on this trend by investing in Research and Development of neurorehabilitation technologies. This increasing patient base creates a robust market environment for the China Neurorehabilitation Devices Market Industry, fostering further advancements in device efficacy and rehabilitation practices. **Government Initiatives and Funding** The Chinese government has been fostering advancements in healthcare technology, particularly in neurorehabilitation, through various initiatives and funding programs. For instance, the National Health Commission of the People's Republic of China has launched the 'Healthy China 2030' initiative, aiming to improve healthcare services and promote the development of advanced medical devices. Reports indicate that government funding for healthcare technology, including neurorehabilitation devices, could reach 2.5 billion USD in the next few years to aid this initiative.This strategic governmental support bolsters the China Neurorehabilitation Devices Market Industry, ensuring manufacturers have the financial resources necessary to innovate and expand their offerings. **Rising Geriatric Population** China's aging population is fueling the growth of the neurorehabilitation devices market. By 2050, it is projected that around 400 million people in China will be aged over 60, according to the National Bureau of Statistics of China. As the geriatric demographic is more prone to neurological conditions such as Alzheimer's disease and Parkinson's disease, the demand for effective rehabilitation solutions is set to surge. Manufacturers like Beijing Siwen Medical Technology Co.Ltd is already developing specialized devices tailored to meet the needs of older adults. The significant demographic trend highlights the potential for the China Neurorehabilitation Devices Market to expand as the focus shifts towards meeting the rehabilitation needs of this growing age group. **China Neurorehabilitation Devices Market Segment Insights** **Neurorehabilitation Devices Market Type Insights** The China Neurorehabilitation Devices Market is experiencing growth across various types of devices aimed at improving the recovery and rehabilitation process for individuals with neurological disorders. Among the types, Neuro-Robotic Devices are gaining significant attention for their ability to provide assisted movement and enhance functional recovery through robotic exoskeletons and rehabilitation robots. This technology not only supports motor function but also encourages patient engagement, making rehabilitation more effective. Wearable Devices are also key players in this market, as they offer portable and user-friendly solutions that enable continuous monitoring of patient's progress.By utilizing sensors and mobile applications, they empower patients to take an active role in their rehabilitation. Non-Invasive Stimulators have emerged as pivotal, utilizing methods such as transcranial magnetic stimulation to stimulate the brain without direct surgery or invasive procedures. This segment is particularly valued for its potential to induce neuroplasticity, aiding in the recovery of lost functions. Additionally, Brain-Computer Interfaces represent a fascinating aspect of the market, allowing direct communication between the brain and external devices to facilitate independence in daily activities. This technology holds the promise of transforming rehabilitation by enabling patients to control devices through thought alone, making it a significant area of focus for future advancements. Collectively, these types of neurorehabilitation devices signify a comprehensive approach towards addressing the needs of patients with neurological impairments in China, reflecting the country's commitment to advancing healthcare technology and improving the quality of life for those affected. As the market evolves, the integration of these technologies is likely to provide enhanced patient outcomes, making China a critical player in the global neurorehabilitation landscape. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Neurorehabilitation Devices Market Application Insights** The Application segment of the China Neurorehabilitation Devices Market is pivotal, spanning a diverse range of conditions that require rehabilitative care. Brain Stroke remains a leading concern, as it significantly impacts rehabilitation efforts and the need for advanced therapeutic devices. Parkinson's Disease also commands attention due to the rising prevalence in the aging population, driving innovation in neurorehabilitation technologies. Multiple Sclerosis, through its complex nature, has necessitated specialized devices catering to the unique challenges faced by patients. The segment also addresses Spinal Cord Injury, which requires sophisticated rehabilitation protocols, highlighting the urgent need for effective devices to enhance recovery. Similarly, Cerebral Palsy represents a significant demographic that benefits from tailored neurorehabilitation solutions, underscoring the market’s response to specific patient needs. Additionally, Schizophrenia management through neurorehabilitation devices is gaining traction, emphasizing a holistic approach to mental and physical health. Overall, the Application segment plays a crucial role in shaping the China Neurorehabilitation Devices Market, driven by the need for therapeutic efficacy and better patient outcomes across these diverse conditions. **Neurorehabilitation Devices Market End User Insights** The China Neurorehabilitation Devices Market, with its diverse applications across various end users, is witnessing significant growth driven by factors such as an increasing elderly population and rising incidences of neurological disorders. Rehabilitation Centers play a crucial role in this market as they focus on providing specialized patient care and therapy, often utilizing advanced neurorehabilitation devices for effective treatment outcomes. Hospitals and Clinics are also key players, offering a range of services that cater to patients requiring acute and long-term neurorehabilitation. This segment is significant as it often integrates cutting-edge technologies, enhancing rehabilitation effectiveness. Home Care solutions are gaining traction as well, reflecting a shift towards more personalized rehabilitation approaches and allowing patients to recover in familiar environments. The demand for neurorehabilitation devices in these end-user settings is driven by the need for tailored recovery processes and improved accessibility, ultimately contributing to the market's overall growth trajectory. With ongoing investments in healthcare infrastructure and advancements in technology, the dynamics of the China Neurorehabilitation Devices Market across these segments are expected to evolve substantially in the coming years. **China Neurorehabilitation Devices Market Key Players and Competitive Insights** The China Neurorehabilitation Devices Market is a rapidly evolving sector characterized by a blend of innovative technologies and increasing demand for rehabilitation solutions. The competitive landscape features various players focusing on advanced neurological therapies, robotic aids, wearable tech, and other forms of neurorehabilitation products and services. The market is driven by a growing awareness of neurological disorders, an aging population, and a greater emphasis on enhancing the quality of life for patients. As a result, companies are investing significantly in research and development, seeking to introduce cutting-edge technologies to gain a competitive edge. Collaborations, partnerships, and strategic alliances are becoming prevalent trends, enabling firms to leverage each other’s strengths to enhance their product portfolios and market reach.NeuroWave is a notable player in the China Neurorehabilitation Devices Market, specializing in innovative neurostimulation technologies aimed at enhancing patient rehabilitation outcomes. The company's strengths lie in its robust research and development capabilities, enabling the creation of effective therapeutic devices tailored to meet the specific needs of patients with neurological impairments. NeuroWave has established a strong market presence by emphasizing quality and effectiveness, which resonates well with healthcare providers and patients alike. Additionally, the company's commitment to user-friendly device designs has contributed to its adoption across various rehabilitation centers in China. By prioritizing customer feedback and investing in continuous improvement, NeuroWave has positioned itself as a leader in the neurorehabilitation domain.Shenzhen Longteng Medical Technology has made significant strides in the China Neurorehabilitation Devices Market with its focus on high-quality rehabilitation solutions. The company offers a range of products designed to aid patients recovering from neurological injuries, such as robotic rehabilitation systems and virtual reality-based therapy tools. Its strengths include a strong distribution network and established relationships with healthcare institutions across China, which facilitate market penetration. Longteng has also engaged in strategic partnerships and alliances to enhance its product offerings and improve service delivery. Recently, the company has pursued mergers and acquisitions to expand its technological capabilities and product ranges in alignment with the growing demands of the market. By continually innovating and adapting to market trends, Shenzhen Longteng Medical Technology has reinforced its presence in the competitive landscape of China’s neurorehabilitation sector. **Key Companies in the China Neurorehabilitation Devices Market Include** - NeuroWave - Shenzhen Longteng Medical Technology - Zhuozhou Huazhong Medical Technology - Xingzhi Intelligent Control - Neuroelectrics - Wuxi Tianyi Medical Equipment - Beijing Lianfu Medical Technology - MindMotion - Reha Technology - Hengrong Technology - Ava Robotics - MicroPort Scientific Corporation - MediPush - Intelligent Rehabilitation Technology - Bionik Laboratories **China Neurorehabilitation Devices Market Industry Developments** Recent developments in the China Neurorehabilitation Devices Market indicate a significant growth trajectory driven by rising demand for advanced technologies in inpatient rehabilitation. Companies such as NeuroWave, Shenzhen Longteng Medical Technology, and Wuxi Tianyi Medical Equipment are increasingly focusing on Research and Development to innovate their product offerings. In March 2023, Neuroelectrics announced enhancements in their neurostimulation devices, aligning with the growing market focus on non-invasive therapies. Major players like MicroPort Scientific Corporation and Reha Technology are pursuing strategic partnerships to expand their market footprint. Notably, in July 2023, Hengrong Technology entered a strategic partnership with Bionik Laboratories to co-develop robotic rehabilitation solutions aimed at stroke recovery. The market is also experiencing a notable shift with an increase in telerehabilitation services, supported by digital health initiatives from the Chinese government, enhancing access to neurorehabilitation devices. Over the last two years, investments in Artificial Intelligence and robotics within the rehabilitation sector have surged, demonstrating the commitment of companies like MindMotion and Intelligent Rehabilitation Technology to leverage technology for improved patient outcomes. **China Neurorehabilitation Devices Market Segmentation Insights** **Neurorehabilitation Devices Market Type****Outlook** - Neuro-Robotic Devices - Wearable Devices - Non-Invasive Stimulators - Brain-Computer Interfaces **Neurorehabilitation Devices Market Application****Outlook** - Brain Stroke - Parkinson's Disease - Multiple Sclerosis - Spinal Cord Injury - Cerebral Palsy - Schizophrenia **Neurorehabilitation Devices Market End User****Outlook** - Rehabilitation Centers - Hospitals & Clinics - Home Care ## Market Drivers ### Increased Healthcare Expenditure China's rising healthcare expenditure is a significant driver for the neurorehabilitation devices market. The government has been increasing its investment in healthcare infrastructure, with spending projected to reach 7.5% of GDP by 2025. This financial commitment is likely to enhance the availability of advanced rehabilitation technologies in hospitals and clinics. As healthcare facilities upgrade their equipment, the demand for neurorehabilitation devices is expected to surge. Additionally, the growing awareness of the importance of rehabilitation in recovery processes is prompting healthcare providers to allocate more resources towards these devices. Consequently, the neurorehabilitation devices market is poised for growth as funding and resources become more readily available to support innovative rehabilitation solutions. ### Government Initiatives and Policies The Chinese government is actively promoting policies aimed at enhancing rehabilitation services, which serves as a crucial driver for the neurorehabilitation devices market. Initiatives such as the Healthy China 2030 plan emphasize the importance of rehabilitation in improving public health outcomes. Additionally, funding programs and subsidies are being introduced to support the development and adoption of innovative rehabilitation technologies. These government efforts are likely to stimulate market growth by encouraging manufacturers to invest in research and development of new devices. As a result, the neurorehabilitation devices market is expected to benefit from a favorable regulatory environment and increased support for rehabilitation initiatives. ### Rising Incidence of Neurological Disorders The increasing prevalence of neurological disorders in China is a primary driver for the neurorehabilitation devices market. Conditions such as stroke, traumatic brain injury, and neurodegenerative diseases are becoming more common, with estimates suggesting that over 7 million individuals in China are affected by stroke alone. This growing patient population necessitates advanced rehabilitation solutions, thereby propelling demand for neurorehabilitation devices. The market is projected to expand as healthcare providers seek effective tools to enhance recovery outcomes. Furthermore, the aging population in China, which is expected to reach 400 million by 2040, further exacerbates the need for innovative rehabilitation technologies. As a result, the neurorehabilitation devices market is likely to witness substantial growth driven by the urgent need to address these health challenges. ### Rising Awareness of Rehabilitation Benefits There is a growing awareness among healthcare professionals and patients regarding the benefits of neurorehabilitation. Educational initiatives and campaigns are being launched to inform the public about the importance of rehabilitation in recovery from neurological conditions. This heightened awareness is leading to an increase in demand for neurorehabilitation devices, as patients and families seek effective solutions for recovery. Furthermore, healthcare providers are increasingly recognizing the value of early intervention and continuous rehabilitation, which is likely to drive the adoption of advanced devices. As a result, the neurorehabilitation devices market is expected to expand as more individuals seek out these technologies to aid in their recovery journeys. ### Technological Advancements in Rehabilitation Technological innovations are significantly influencing the neurorehabilitation devices market. The integration of robotics, artificial intelligence, and virtual reality into rehabilitation practices is transforming patient care. For instance, robotic exoskeletons and smart rehabilitation devices are being developed to provide personalized therapy, enhancing patient engagement and recovery rates. The market for these advanced devices is expected to grow at a CAGR of approximately 15% over the next five years. Moreover, the adoption of tele-rehabilitation solutions is on the rise, allowing patients to receive therapy remotely, which is particularly beneficial in rural areas of China. These advancements not only improve the efficacy of rehabilitation but also expand access to care, thereby driving the growth of the neurorehabilitation devices market. ## Future Outlook The [Neurorehabilitation Devices Market](https://www.marketresearchfuture.com/reports/neurorehabilitation-devices-market-2210) in China is projected to grow at a 9.04% CAGR from 2025 to 2035, driven by technological advancements and increasing patient demand. **New opportunities:** - Development of AI-driven rehabilitation software solutions - Expansion of tele-rehabilitation services for remote patient monitoring - Partnerships with healthcare providers for integrated device solutions By 2035, the market is expected to achieve substantial growth and innovation. ## Segment Insights ### China Neurorehabilitation Devices Market Segment Insights China Neurorehabilitation Devices Market Segment Insights ### Neurorehabilitation Devices Market Type Insights Neurorehabilitation Devices Market Type Insights The China [Neurorehabilitation Devices Market](https://www.marketresearchfuture.com/reports/neurorehabilitation-devices-market-2210) is experiencing growth across various types of devices aimed at improving the recovery and rehabilitation process for individuals with neurological disorders. Among the types, Neuro-Robotic Devices are gaining significant attention for their ability to provide assisted movement and enhance functional recovery through robotic exoskeletons and rehabilitation robots. This technology not only supports motor function but also encourages patient engagement, making rehabilitation more effective. Wearable Devices are also key players in this market, as they offer portable and user-friendly solutions that enable continuous monitoring of patient's progress.By utilizing sensors and mobile applications, they empower patients to take an active role in their rehabilitation. Non-Invasive Stimulators have emerged as pivotal, utilizing methods such as transcranial magnetic stimulation to stimulate the brain without direct surgery or invasive procedures. This segment is particularly valued for its potential to induce neuroplasticity, aiding in the recovery of lost functions. Additionally, Brain-Computer Interfaces represent a fascinating aspect of the market, allowing direct communication between the brain and external devices to facilitate independence in daily activities. This technology holds the promise of transforming rehabilitation by enabling patients to control devices through thought alone, making it a significant area of focus for future advancements. ### Neurorehabilitation Devices Market Application Insights Neurorehabilitation Devices Market Application Insights The Application segment of the China Neurorehabilitation Devices Market is pivotal, spanning a diverse range of conditions that require rehabilitative care. Brain Stroke remains a leading concern, as it significantly impacts rehabilitation efforts and the need for advanced therapeutic devices. Parkinson's Disease also commands attention due to the rising prevalence in the aging population, driving innovation in neurorehabilitation technologies. Multiple Sclerosis, through its complex nature, has necessitated specialized devices catering to the unique challenges faced by patients. The segment also addresses Spinal Cord Injury, which requires sophisticated rehabilitation protocols, highlighting the urgent need for effective devices to enhance recovery. Similarly, Cerebral Palsy represents a significant demographic that benefits from tailored neurorehabilitation solutions, underscoring the market’s response to specific patient needs. Additionally, Schizophrenia management through neurorehabilitation devices is gaining traction, emphasizing a holistic approach to mental and physical health. Overall, the Application segment plays a crucial role in shaping the China Neurorehabilitation Devices Market, driven by the need for therapeutic efficacy and better patient outcomes across these diverse conditions. ### Neurorehabilitation Devices Market End User Insights Neurorehabilitation Devices Market End User Insights The China Neurorehabilitation Devices Market, with its diverse applications across various end users, is witnessing significant growth driven by factors such as an increasing elderly population and rising incidences of neurological disorders. Rehabilitation Centers play a crucial role in this market as they focus on providing specialized patient care and therapy, often utilizing advanced neurorehabilitation devices for effective treatment outcomes. Hospitals and Clinics are also key players, offering a range of services that cater to patients requiring acute and long-term neurorehabilitation. This segment is significant as it often integrates cutting-edge technologies, enhancing rehabilitation effectiveness. Home Care solutions are gaining traction as well, reflecting a shift towards more personalized rehabilitation approaches and allowing patients to recover in familiar environments. The demand for neurorehabilitation devices in these end-user settings is driven by the need for tailored recovery processes and improved accessibility, ultimately contributing to the market's overall growth trajectory. With ongoing investments in healthcare infrastructure and advancements in technology, the dynamics of the China Neurorehabilitation Devices Market across these segments are expected to evolve substantially in the coming years. ## Competitive Benchmarking The neurorehabilitation devices market in China is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for effective rehabilitation solutions. Key players such as ReWalk Robotics (IL), Ekso Bionics (US), and Medtronic (US) are at the forefront, each adopting distinct strategies to enhance their market presence. ReWalk Robotics (IL) focuses on innovation in exoskeleton technology, aiming to improve mobility for individuals with spinal cord injuries. Meanwhile, Ekso Bionics (US) emphasizes partnerships with rehabilitation centers to expand its reach and integrate its devices into clinical practices. Medtronic (US) leverages its extensive portfolio in medical devices to incorporate neurorehabilitation solutions, indicating a strategic focus on comprehensive patient care. Collectively, these strategies contribute to a competitive environment that is increasingly centered on technological innovation and collaborative efforts. In terms of business tactics, companies are localizing manufacturing to reduce costs and enhance supply chain efficiency. This approach is particularly relevant in a moderately fragmented market where several players vie for market share. The collective influence of these key players shapes the market structure, fostering an environment where innovation and operational efficiency are paramount. As companies optimize their supply chains and adapt to local market needs, they position themselves to better respond to the evolving demands of healthcare providers and patients alike. In October 2025, ReWalk Robotics (IL) announced a strategic partnership with a leading rehabilitation hospital in Shanghai to pilot its latest exoskeleton model. This collaboration is significant as it not only enhances the company's visibility in the Chinese market but also allows for real-world testing and feedback, potentially leading to further innovations tailored to local needs. Such partnerships are likely to bolster ReWalk's competitive edge by integrating its technology into established rehabilitation practices. In September 2025, Ekso Bionics (US) launched a new version of its EksoGT exoskeleton, which features advanced AI capabilities for personalized rehabilitation. This development underscores the company's commitment to integrating cutting-edge technology into its products, thereby enhancing user experience and outcomes. The introduction of AI-driven features may position Ekso Bionics as a leader in the market, appealing to both healthcare providers and patients seeking effective rehabilitation solutions. In August 2025, Medtronic (US) expanded its neurorehabilitation product line by acquiring a startup specializing in brain-computer interface technology. This acquisition is indicative of Medtronic's strategy to diversify its offerings and enhance its technological capabilities. By integrating brain-computer interfaces with traditional rehabilitation devices, Medtronic could potentially revolutionize the rehabilitation process, making it more efficient and tailored to individual patient needs. As of November 2025, the competitive trends in the neurorehabilitation devices market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among companies are shaping the landscape, fostering innovation and enhancing product offerings. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological innovation, reliability in supply chains, and the ability to deliver personalized rehabilitation solutions. This shift may redefine how companies position themselves in the market, emphasizing the importance of adaptability and forward-thinking strategies. ## Recent News & Developments Recent developments in the China Neurorehabilitation Devices Market indicate a significant growth trajectory driven by rising demand for advanced technologies in inpatient rehabilitation. Companies such as NeuroWave, Shenzhen Longteng Medical Technology, and Wuxi Tianyi Medical Equipment are increasingly focusing on Research and Development to innovate their product offerings. In March 2023, Neuroelectrics announced enhancements in their neurostimulation devices, aligning with the growing market focus on non-invasive therapies. Major players like MicroPort Scientific Corporation and Reha Technology are pursuing strategic partnerships to expand their market footprint. Notably, in July 2023, Hengrong Technology entered a strategic partnership with Bionik Laboratories to co-develop robotic rehabilitation solutions aimed at stroke recovery. The market is also experiencing a notable shift with an increase in telerehabilitation services, supported by digital health initiatives from the Chinese government, enhancing access to neurorehabilitation devices. Over the last two years, investments in Artificial Intelligence and robotics within the rehabilitation sector have surged, demonstrating the commitment of companies like MindMotion and Intelligent Rehabilitation Technology to leverage technology for improved patient outcomes. ## Report Scope | MARKET SIZE 2024 | 65.49(USD Million) | | --- | --- | | MARKET SIZE 2025 | 71.41(USD Million) | | MARKET SIZE 2035 | 169.71(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.04% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | ReWalk Robotics (IL), Ekso Bionics (US), Medtronic (US), Bionik Laboratories (CA), AlterG (US), NeuroPace (US), Hocoma (CH), Tyromotion (AT), Kessler Foundation (US) | | Segments Covered | Type, Application, End-User | | Key Market Opportunities | Integration of artificial intelligence in neurorehabilitation devices enhances personalized patient care and treatment outcomes. | | Key Market Dynamics | Technological advancements and regulatory support drive growth in the neurorehabilitation devices market. | | Countries Covered | China | ## Frequently Asked Questions **Q: What is the current valuation of the neurorehabilitation devices market in China as of 2024?** A: The market valuation was $65.49 Million in 2024. **Q: What is the projected market valuation for neurorehabilitation devices in China by 2035?** A: The projected valuation for 2035 is $169.71 Million. **Q: What is the expected CAGR for the neurorehabilitation devices market in China during the forecast period 2025 - 2035?** A: The expected CAGR during this period is 9.04%. **Q: Which segments are included in the neurorehabilitation devices market in China?** A: The segments include Neuro-Robotic Devices, Wearable Medical Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces. **Q: What was the market size for Neuro-Robotic Devices in 2024?** A: The market size for Neuro-Robotic Devices was $15.0 Million in 2024. **Q: How much is the market for Wearable Medical Devices projected to grow by 2035?** A: The market for Wearable Medical Devices is projected to grow to $50.0 Million by 2035. **Q: What applications are driving the neurorehabilitation devices market in China?** A: Key applications include Brain Stroke, Parkinson's Disease, Multiple Sclerosis, and Spinal Cord Injury. **Q: What was the market size for hospitals and clinics in the neurorehabilitation devices market in 2024?** A: The market size for hospitals and clinics was $25.0 Million in 2024. **Q: Which companies are considered key players in the neurorehabilitation devices market in China?** A: Key players include ReWalk Robotics, Ekso Bionics, Medtronic, and Bionik Laboratories. **Q: What is the projected market size for Non-Invasive Stimulators by 2035?** A: The projected market size for Non-Invasive Stimulators is $42.0 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/china-neurorehabilitation-devices-market-56057*